Field trials of a single dose of the combination rifampicin-ofloxacin-minocycline (ROM) for the treatment of paucibacillary leprosy.
Gupte
M D
MD
National Institute of Epidemiology, Chetput, Chennai, India.
D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D007194:India; D007917:Leprostatic Agents / Q000008:administration & dosage*; D007918:Leprosy / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D008911:Minocycline / Q000008:administration & dosage*; D015242:Ofloxacin / Q000008:administration & dosage*; D011379:Prognosis; D012293:Rifampin / Q000008:administration & dosage*; D016896:Treatment Outcome
D007917:Leprostatic Agents; D015242:Ofloxacin; D008911:Minocycline; D012293:Rifampin